AAAAAA
Results: 101-125/325
Authors:
SOUVIGNIER ST
MAYER JA
ECKHARDT L
Citation: St. Souvignier et al., EDUCATING THE PUBLIC ABOUT SKIN-CANCER PREVENTION - A ROLE FOR PHARMACISTS, Journal of clinical pharmacy and therapeutics, 21(6), 1996, pp. 399-406
Authors:
WONG J
BROWN G
Citation: J. Wong et G. Brown, DOES ONCE-DAILY DOSING OF AMINOGLYCOSIDES AFFECT NEUROMUSCULAR FUNCTION, Journal of clinical pharmacy and therapeutics, 21(6), 1996, pp. 407-411
Authors:
RICHARDSON J
TRUMAN C
Citation: J. Richardson et C. Truman, AN AUDIT OF DISCHARGE MEDICATION FOR SECONDARY PROPHYLAXIS POSTMYOCARDIAL INFARCTION, Journal of clinical pharmacy and therapeutics, 21(6), 1996, pp. 413-416
Authors:
DEGATTA MMF
MENDEZ ME
ROMANO S
CALVO MV
DOMINGUEZGIL A
LANAO JM
Citation: Mmf. Degatta et al., PHARMACOKINETICS OF AMIKACIN IN INTENSIVE-CARE UNIT PATIENTS, Journal of clinical pharmacy and therapeutics, 21(6), 1996, pp. 417-421
Authors:
CARLSTEN A
WENNBERG M
BERGENDAL L
Citation: A. Carlsten et al., THE INFLUENCE OF RX-TO-OTC CHANGES ON DRUG SALES - EXPERIENCES FROM SWEDEN 1980-1994, Journal of clinical pharmacy and therapeutics, 21(6), 1996, pp. 423-430
Authors:
NAHATA MC
Citation: Mc. Nahata, DRUG-COMBINATIONS IN INDIA, Journal of clinical pharmacy and therapeutics, 21(5), 1996, pp. 283-284
Authors:
KILWEIN JH
Citation: Jh. Kilwein, THE PERVERSION OF HEALTH-CARE - FROM A SOCIAL GOOD TO A COMMODITY, Journal of clinical pharmacy and therapeutics, 21(5), 1996, pp. 285-287
Authors:
EAGLES CJ
GULATI R
MARTIN U
Citation: Cj. Eagles et al., NONPHARMACOLOGICAL MODIFICATION OF CARDIAC RISK-FACTORS .1., Journal of clinical pharmacy and therapeutics, 21(5), 1996, pp. 289-296
Authors:
CHEAH SY
CLARK C
GOLDBERG L
PO ALW
PHILLIPS R
Citation: Sy. Cheah et al., OUTCOME MEASURES, POOLED INDEX AND QUALITY-OF-LIFE INSTRUMENTS IN RHEUMATOID-ARTHRITIS, Journal of clinical pharmacy and therapeutics, 21(5), 1996, pp. 297-316
Authors:
JACOBSON GA
PETERSON GM
Citation: Ga. Jacobson et Gm. Peterson, PRESCRIBING TRENDS FOR ANTIASTHMA DRUGS IN TASMANIA FOLLOWING THE NATIONAL ASTHMA CAMPAIGN, Journal of clinical pharmacy and therapeutics, 21(5), 1996, pp. 317-324
Authors:
CHAN TYK
LEE KKC
CRITCHLEY JAJH
Citation: Tyk. Chan et al., THE NEEDS AND SOURCES OF DRUG INFORMATION AMONG PHARMACISTS IN HONG-KONG, Journal of clinical pharmacy and therapeutics, 21(5), 1996, pp. 325-330
Authors:
BURGAZ S
TORUN M
YARDIM S
SARGIN H
ORMAN MN
OZDAMAR NY
Citation: S. Burgaz et al., SERUM CAROTENOIDS AND URIC-ACID LEVELS IN RELATION TO CANCER, Journal of clinical pharmacy and therapeutics, 21(5), 1996, pp. 331-336
Authors:
ODOU P
FRIMAT B
FONTAINE B
LUYCKX M
BRUNET C
ROBERT H
DINE T
GRESSIER B
CAZIN M
CAZIN JC
Citation: P. Odou et al., DETERMINATION OF CLOZAPINE IN SERUM BY RADIORECEPTOR ASSAY VERSUS HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - POSSIBLE DETECTION OF HYDROXY-METABOLITES, Journal of clinical pharmacy and therapeutics, 21(5), 1996, pp. 337-342
Authors:
BAINES DL
TOLLEY KH
WHYNES DK
Citation: Dl. Baines et al., THE COSTS OF PRESCRIBING IN DISPENSING PRACTICES, Journal of clinical pharmacy and therapeutics, 21(5), 1996, pp. 343-348
Authors:
DEOLIVEIRA IR
MIRANDASCIPPA AMA
DESENA EP
PEREIRA ELA
RIBEIRO MG
DECASTROESILVA E
BACALTCHUK J
Citation: Ir. Deoliveira et al., RISPERIDONE VERSUS HALOPERIDOL IN THE TREATMENT OF SCHIZOPHRENIA - A METAANALYSIS COMPARING THEIR EFFICACY AND SAFETY, Journal of clinical pharmacy and therapeutics, 21(5), 1996, pp. 349-358
Authors:
DURSO P
Citation: P. Durso, ABUSE OF SERTRALINE, Journal of clinical pharmacy and therapeutics, 21(5), 1996, pp. 359-360
Authors:
KILWEIN JH
Citation: Jh. Kilwein, MY FAVORITE IRISHMAN, Journal of clinical pharmacy and therapeutics, 21(4), 1996, pp. 191-193
Authors:
CLARK W
Citation: W. Clark, THERAPEUTIC ADVANCES - INTERFERON-BETA FOR MULTIPLE-SCLEROSIS, Journal of clinical pharmacy and therapeutics, 21(4), 1996, pp. 195-199
Authors:
LEE SD
LEE WI
SHIM HJ
LEE ED
KIM WB
YANG J
KIM CK
LEE MG
Citation: Sd. Lee et al., PHARMACOKINETICS OF 4 METABOLITES OF DA-125, A NEW ANTHRACYCLINE ANTINEOPLASTIC AGENT AFTER SINGLE AND MULTIPLE INTRAVENOUS ADMINISTRATION TO RATS, Journal of clinical pharmacy and therapeutics, 21(4), 1996, pp. 201-213
Authors:
PETERSON GM
BERGIN JK
NELSON BJ
STANTON LA
Citation: Gm. Peterson et al., IMPROVING DRUG-USE IN RHEUMATIC DISORDERS, Journal of clinical pharmacy and therapeutics, 21(4), 1996, pp. 215-220
Authors:
LYONS RF
RUMORE MM
MEROLA MR
Citation: Rf. Lyons et al., AN ANALYSIS OF DRUG INFORMATION DESIRED BY THE PATIENT - (ARE PATIENTS BEING TOLD EVERYTHING THEY WISH TO KNOW UNDER OBRA-90), Journal of clinical pharmacy and therapeutics, 21(4), 1996, pp. 221-228
Authors:
DEOLIVEIRA IR
DESENA EP
PEREIRA ELA
MIRANDA AMA
DEOLIVEIRA NF
RIBEIRO MG
DECASTROESILVA E
DARDENNES RM
SAMUELLAJEUNESSE B
MARCILIO C
Citation: Ir. Deoliveira et al., HALOPERIDOL BLOOD-LEVELS AND CLINICAL OUTCOME - A METAANALYSIS OF STUDIES RELEVANT TO TESTING THE THERAPEUTIC WINDOW HYPOTHESIS, Journal of clinical pharmacy and therapeutics, 21(4), 1996, pp. 229-236
Authors:
TRUTER I
KOTZE TJV
Citation: I. Truter et Tjv. Kotze, AN INVESTIGATION INTO THE PRESCRIBING PATTERNS OF SELECTIVE SEROTONINREUPTAKE INHIBITORS IN SOUTH-AFRICA, Journal of clinical pharmacy and therapeutics, 21(4), 1996, pp. 237-242
Authors:
TREWIN VF
LAWRENCE CJ
VEITCH GBA
PEARCE V
Citation: Vf. Trewin et al., CHANGES IN PRESCRIBING PATTERNS OF ORAL HYPOGLYCEMICS IN ELDERLY PATIENTS, OVER A PERIOD OF 10 YEARS - MATCHING WITH GENERAL-PRACTITIONERS PERCEPTIONS OF THEIR OWN PRESCRIBING, Journal of clinical pharmacy and therapeutics, 21(4), 1996, pp. 243-245
Authors:
BRAYBROOK S
WALKER R
Citation: S. Braybrook et R. Walker, INFLUENCING PRESCRIBING IN PRIMARY-CARE - A COMPARISON OF 2 DIFFERENTPRESCRIBING FEEDBACK METHODS, Journal of clinical pharmacy and therapeutics, 21(4), 1996, pp. 247-254